Peer Review History
| Original SubmissionJune 24, 2024 |
|---|
|
PONE-D-24-25259Modelling the drivers of outbreak communication from event-based surveillance for improved epidemic intelligencePLOS ONE Dear Dr. Arsevska, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 28 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Fernanda C. Dórea Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure:H2020 MOOD project Grant agreement ID: 874850: https://cordis.europa.eu/project/id/874850 Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. Additional Editor Comments: Dear authors, our sincere apologies for the delay. I took a decision to seek 3 reviewers to make sure that we were giving you a fair and balanced review. The reviewers raised important concerns related to ensuring that the utility of the tool is accurately represented, and two of the two reviewers recommended rigorous consideration (review or at least more explanations) of the statistical methods used. I ask you to please consider their comments thoughtfully and look forward to a revised version of your manuscript. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: No Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Overall, this manuscript is well-written and the findings highlighted will be useful to those responsible for conducting event-based surveillance using digital platforms and practitioners of epidemic intelligence. It would be helpful if the authors could further explain the rationale for selecting news report dates restricted from July 1 2018 to June 30 2019. Were there concerns about different dynamics during the COVID-19 pandemic in 2020 and later? Were cases of AI and ASF particularly elevated at this time? Given that these data are roughly 5 years old, it would be helpful to understand why more recent data were not incorporated, as the online new environment is quite dynamic. Given that findings that WOAH is one of the primary sources for AI and ASF, the authors might consider commenting on the implications of health authorities being the primary source vs. news agencies (e.g. what is the relative value of EBS systems picking up these reports if health authorities are already aware of the event?). Reviewer #2: Thank you so much for submitting this work for review. There is a growing trend in the use of media aggregators to assist in media scanning efforts to inform EI and EWAR. It is great to see other tools being represented in the literature that may not be as well known as EIOS and ProMed. With regard to this analysis, I have concerns about the subtle reference that internet-based media scanning represents a timely method of event-based surveillance to inform EWAR efforts. Media scanning is one of several other EBS modalities (media, hotline, community, and facility) that can be implemented at a country level to inform EWAR. Community is often considered the gold standard for timeliness as it picks up events even before they reach the media. Within countries, internet-based media scanning may also not be the most efficient method for tracking signals and events as much of the local media, especially social media is not currently included as a source by many of the popular aggregators. This limitation of these media aggregators can skew the ability to understand the true situation within a country or region for those not familiar with local context. Given this stated limitation of the tool that you used, I worry that the outcomes presented in this manuscript do not truly reflect the factors/drivers of outbreak communication on a global scale and in fact give an over-representation of systems in European and English-speaking countries. It would be helpful to potentially compare this tool to other aggregators and other methods of conducting EBS to fully understand the drivers of outbreak communication globally - OR maybe a better approach would be to limit the analysis to CIRAD's global internet-based media scanning efforts and speak to how representative this is for your work and where the current gaps exist in the method's currently being used that need to be improved to gain a better global picture. Additionally the methods you listed for collecting and verifying reports needs additional attention which may have unintentionally skewed your results as well. I have listed more detailed comments in the attached pdf for your consideration. Reviewer #3: Thank you for the well written article on the topic of EI. The article addresses important aspects of EI and a better understanding of EI sources can have a benefitial impact on the entire process and provides potentially helpful insights for EI practitioners. The article provides a clear description of methods and results and makes no exaggerated claims. Some of the limitations are already discussed in the paper itself, such as the inclusion of english-only search queries and the missing of the time-aspect in the analysis. Given that, the covariate for english language should either be discarded in the analysis or intepredted differently in the results. Including the time-aspect in the analysis may provide further interesting insights. While the usage of a bipartite network may be statistically correct, it is not clear why that is the most appropriate statistical method for the given dataset. Most of the descriptive statistics could have been achieved in a simpler way and also the computation of ORs would be possible through simple regression methods. If there are reasons for the necessity of networks, it should be made more clear. The data and scripts is made available in a very good way and format. However, you here provide the constructed network, while more detailed information of the news articles or maybe even the articles itself are not available. This maybe benefitial for other researchers to follow up on the research. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-24-25259R1Modelling the drivers of outbreak communication in online media news for improved event-based surveillancePLOS ONE Dear Dr. Arsevska, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 12 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Fernanda C. Dórea Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Dear authors, thank you for your revised submission. Overall, I agree with Reviewer 3 that the article provides a clear description of methods and results and makes no exaggerated claims. However, I find the discussion and conclusions still very weak. Reviewer 3 specifically asked "what is the relative value of EBS systems picking up these reports if health authorities are already aware of the event?", and I don't feel that this question was addressed in the paper or sufficiently answered. In addition, there was a question about whether the dataset was not analysed before and after the official WOAH notification, and the authors responded to this in the response letter stating that the dataset was too small to do this. But this is not reflected in the discussion, and the readers of the paper are still left wondering why this was not done. In addition to explaining why this could not be done, you should discuss what are you really able to conclude given this shortcoming, considering the question above regarding the value of EBS if the main sources are official ones. These two issues are linked. A very small part of the discussion is focused on discussing the meaning of the results, and I don't feel it leaves readers with a clear message on the main insights learned, and how they help better implement or better use the results of EBS. I understand your explanations for why language was not removed form the model, but the discussion seems to try to make sense of language biases as if they were a meaningful result, rather than explicitly pointing it out as an artifact of the methods. You state for example "Our results also showed that language and geography may be related". This is not a result brough to light by this work, this is just a fact. How this fact impacts the validity and should be taken into account when interpreting your results is the real information needed in the discussion. The conclusion paragraph, in particular, gives no specific insight on what is the take home message of this paper, and what novel knowledge it provided. It states "we provide first insight that can guide practitioners when monitoring online media for EI purposes". What are those main insights and HOW are they able to guide practicioners? This point in particular - how do the insights of this paper help practicioners of EBS - is in my opinion never really made clear. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Modelling the drivers of outbreak communication in online media news for improved event-based surveillance PONE-D-24-25259R2 Dear Dr. Arsevska, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Fernanda C. Dórea Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #4: The authors have addressed the previous comments adequately and done an excellent job analyzing the data and presenting the results. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #4: Yes: Thomas W Valente ********** |
| Formally Accepted |
|
PONE-D-24-25259R2 PLOS ONE Dear Dr. Arsevska, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Fernanda C. Dórea Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .